5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity.
Saved in:
| Title: | 5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity. |
|---|---|
| Authors: | Hwang KS; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea., Ahn SH; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea., Son Y; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea., Kim SS; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea., Shin DS; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea., Yang JY; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea., Chae CH; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea., Nakamura M; Department of Pharmacology, School of Dentistry, Kyungpook National University, Daegu 41940, Republic of Korea.; Brain Science & Engineering Institute, Kyungpook National University, Daegu 41940, Republic of Korea., Jang IS; Department of Pharmacology, School of Dentistry, Kyungpook National University, Daegu 41940, Republic of Korea.; Brain Science & Engineering Institute, Kyungpook National University, Daegu 41940, Republic of Korea., Kim G; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.; Department of Medical Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, Republic of Korea., Kim DG; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea., Kim P; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea., Heo Y; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea., Bae S; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea., Lee H; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea., Ahn JH; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.; JD Bioscience Inc., 208 Cheomdan-dwagiro, Buk-gu, Gwangju 61011, Republic of Korea., Bae MA; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.; Department of Medical Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, Republic of Korea. |
| Source: | Molecules (Basel, Switzerland) [Molecules] 2026 May 01; Vol. 31 (9). Date of Electronic Publication: 2026 May 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42123875 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hwang+KS%22">Hwang KS</searchLink>; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Ahn+SH%22">Ahn SH</searchLink>; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Son+Y%22">Son Y</searchLink>; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+SS%22">Kim SS</searchLink>; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Shin+DS%22">Shin DS</searchLink>; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yang+JY%22">Yang JY</searchLink>; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Chae+CH%22">Chae CH</searchLink>; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Nakamura+M%22">Nakamura M</searchLink>; Department of Pharmacology, School of Dentistry, Kyungpook National University, Daegu 41940, Republic of Korea.; Brain Science & Engineering Institute, Kyungpook National University, Daegu 41940, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jang+IS%22">Jang IS</searchLink>; Department of Pharmacology, School of Dentistry, Kyungpook National University, Daegu 41940, Republic of Korea.; Brain Science & Engineering Institute, Kyungpook National University, Daegu 41940, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+G%22">Kim G</searchLink>; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.; Department of Medical Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+DG%22">Kim DG</searchLink>; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+P%22">Kim P</searchLink>; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Heo+Y%22">Heo Y</searchLink>; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Bae+S%22">Bae S</searchLink>; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+H%22">Lee H</searchLink>; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Ahn+JH%22">Ahn JH</searchLink>; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.; JD Bioscience Inc., 208 Cheomdan-dwagiro, Buk-gu, Gwangju 61011, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Bae+MA%22">Bae MA</searchLink>; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.; Department of Medical Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, Republic of Korea. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100964009%22">Molecules (Basel, Switzerland)</searchLink> [Molecules] 2026 May 01; Vol. 31 (9). <i>Date of Electronic Publication: </i>2026 May 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>100964009 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1420-3049 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214203049%22">14203049 </searchLink><i>NLM ISO Abbreviation: </i>Molecules <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42123875 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/molecules31091511 Languages: – Code: eng Text: English Titles: – TitleFull: 5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hwang KS – PersonEntity: Name: NameFull: Ahn SH – PersonEntity: Name: NameFull: Son Y – PersonEntity: Name: NameFull: Kim SS – PersonEntity: Name: NameFull: Shin DS – PersonEntity: Name: NameFull: Yang JY – PersonEntity: Name: NameFull: Chae CH – PersonEntity: Name: NameFull: Nakamura M – PersonEntity: Name: NameFull: Jang IS – PersonEntity: Name: NameFull: Kim G – PersonEntity: Name: NameFull: Kim DG – PersonEntity: Name: NameFull: Kim P – PersonEntity: Name: NameFull: Heo Y – PersonEntity: Name: NameFull: Bae S – PersonEntity: Name: NameFull: Lee H – PersonEntity: Name: NameFull: Ahn JH – PersonEntity: Name: NameFull: Bae MA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1420-3049 Numbering: – Type: volume Value: 31 – Type: issue Value: 9 Titles: – TitleFull: Molecules (Basel, Switzerland) Type: main |
| ResultId | 1 |